The goal is not to eat normally but to eat optimally, prioritizing protein, fiber, and nutrient-dense foods within a reduced caloric window
In an analysis of more than 6,800 colon cancer patients across all University of California Health sites, researchers found that those taking glucagon-like peptide-1 (GLP-1) medications were less than half as likely to die within five years compared to those who werent on the drugs (15.5% vs
SeekPeptides has compiled research from prescribing information, pharmacokinetic studies, and clinical guidelines to give you the most complete answer available
By improving insulin sensitivity and reducing compensatory hyperinsulinaemia, these medications may help address the hormonal imbalances that drive androgen excess
The side effect burden is manageable, and the weight loss is clinically meaningful
Inconsistent levels lead to poor results and frustration